Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Systematic review of pharmacological treatments in fragile X syndrome
BMC Neurology, 10/16/09
Rueda JR et al. – Currently there is no robust evidence to support recommendations on pharmacological treatments in patients with FXS in general or in those with an additional diagnosis of ADHD or autism.
Related Articles
FUS-Immunoreactive Intranuclear Inclusions in Neurodegenerative Disease
Brain Pathology, 10/16/09
Relevance Score: 78%
Characterization of a new X-linked mental retardation syndrome with microcephaly, cortical malformation, and thin habitus
American Journal of Medical Genetics, 10/23/09
Relevance Score: 67%
Munchausen syndrome in the emergency department mostly difficult, sometimes easy to diagnose: a case report and review of the literature
World Journal of Emergency Surgery, 11/16/09
Relevance Score: 66%
Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancer
Annals of Oncology, 10/29/09
Relevance Score: 66%
The Metabolic Syndrome: A Modern Plague Spread by Modern Technology
The Journal of Clinical Hypertension, 10/06/09
Relevance Score: 66%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy
Journal of Neuro-Oncology, 12/04/09
Combination therapy of 17(beta)-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke
Journal of Pharmacology and Experimental Therapeutics, 12/04/09
Glutamatergic (N-methyl-D-aspartate receptor) hypofrontality in schizophrenia: Too little juice or a miswired brain
Molecular Pharmacology, 12/04/09
Sponsor
Article Search
Sponsor


See Latest Articles


